As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Eli Lilly and Company: CTC LLC, Barclays PLC, National Bank of Canada FI, Jane Street Group LLC, Wolverine Trading LLC, Readystate Asset Management LP, Point72 DIFC Ltd, Parallax Volatility Advisers L.P., Maven Securities LTD, Centiva Capital LP, Paloma Partners Management Co, Garda Capital Partners LP, Verition Fund Management LLC, Capstone Investment Advisors LLC, Walleye Trading LLC, Walleye Capital LLC, Crawford Fund Management LLC, Summit Partners Public Asset Management LLC, PEAK6 Investments LLC, BNP Paribas Financial Markets, Bank of Montreal Can, Covenant Asset Management LLC, Citigroup Inc., LPL Financial LLC, One River Asset Management LLC, MAI Capital Management, Gladius Capital Management LP, Wolverine Asset Management LLC, SpiderRock Advisors LLC, Carmichael Hill & Associates Inc., Genus Capital Management Inc., Caas Capital Management LP, US Bancorp DE, XR Securities LLC, Fortitude Family Office LLC, Wealth Enhancement Advisory Services LLC, Heritage Wealth Management Inc. CA , Raymond James & Associates, Concourse Financial Group Securities Inc., Oak Hill Wealth Advisors LLC, Valeo Financial Advisors LLC, Point72 DIFC Ltd, Cubist Systematic Strategies LLC, and Maven Securities LTD. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.